当前位置:首页 - 行情中心 - 凯普生物(300639) - 财务分析 - 现金流量表

凯普生物

(300639)

  

流通市值:37.86亿  总市值:38.53亿
流通股本:6.35亿   总股本:6.47亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金445,799,579.1230,220,258.291,028,859,142.74775,073,551.44
  收到的税费返还121,127.624,118.5812,651,730.79304,056.87
  收到其他与经营活动有关的现金16,745,086.3811,788,058.5734,013,120.4429,422,208.83
  经营活动现金流入小计462,665,793.1242,012,435.441,075,523,993.97804,799,817.14
  购买商品、接受劳务支付的现金94,681,292.743,192,726.9170,725,614.95144,995,396.5
  支付给职工以及为职工支付的现金170,111,506.1788,467,544.45380,422,590.77298,064,756.63
  支付的各项税费23,459,508.537,351,405.53129,876,330.05115,959,074.83
  支付其他与经营活动有关的现金119,009,885.4656,082,761.06315,721,006.69201,391,178.47
  经营活动现金流出小计407,262,192.86195,094,437.94996,745,542.46760,410,406.43
  经营活动产生的现金流量净额55,403,600.2446,917,997.578,778,451.5144,389,410.71
二、投资活动产生的现金流量:
  收回投资收到的现金405,000,102.76116,000,102.76694,414,259.16580,000,000
  取得投资收益收到的现金1,309,106.63877,983.34-3,316,889.3
  处置固定资产、无形资产和其他长期资产收回的现金净额601,83838398,798.64102,202.8
  投资活动现金流入小计406,911,047.39116,878,124.1694,813,057.8583,419,092.1
  购建固定资产、无形资产和其他长期资产支付的现金32,087,894.9215,892,794.73148,332,554.69130,471,384.2
  投资支付的现金116,000,000116,000,000656,830,239.79285,000,001
  投资活动现金流出小计148,087,894.92131,892,794.73805,162,794.48415,471,385.2
  投资活动产生的现金流量净额258,823,152.47-15,014,670.63-110,349,736.68167,947,706.9
三、筹资活动产生的现金流量:
  吸收投资收到的现金8,000,0008,000,000--
  其中:子公司吸收少数股东投资收到的现金8,000,0008,000,000--
  取得借款收到的现金45,000,00045,000,00055,318,59255,318,592
  筹资活动现金流入小计53,000,00053,000,00055,318,59255,318,592
  偿还债务支付的现金2,475,400011,617,50011,617,500
  分配股利、利润或偿付利息支付的现金1,576,370.55180,774.9944,458,297.5745,124,610.78
  其中:子公司支付给少数股东的股利、利润-0--
  支付其他与筹资活动有关的现金102,129,656.9868,517,304.0974,511,344.4864,763,853.52
  筹资活动现金流出小计106,181,427.5368,698,079.08130,587,142.05121,505,964.3
  筹资活动产生的现金流量净额-53,181,427.53-15,698,079.08-75,268,550.05-66,187,372.3
四、汇率变动对现金及现金等价物的影响-3,176,317.34-1,261,977.637,587,913.7-1,615,182.43
五、现金及现金等价物净增加额257,869,007.8414,943,270.16-99,251,921.52144,534,562.88
  加:期初现金及现金等价物余额662,115,776.09672,218,393.15761,367,697.61761,367,697.61
  期末现金及现金等价物余额919,984,783.93687,161,663.31662,115,776.09905,902,260.49
补充资料:
  净利润-137,116,800.36--950,350,169.79-
  资产减值准备68,458,178.12-645,751,881.06-
  固定资产和投资性房地产折旧65,265,442.69-147,747,213.17-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧65,265,442.69-147,747,213.17-
  无形资产摊销6,738,050.65-12,763,125.08-
  长期待摊费用摊销14,995,090.89-28,627,058.54-
  处置固定资产、无形资产和其他长期资产的损失-358,182.51-248,851.5-
  固定资产报废损失157,863.35-668,788.92-
  公允价值变动损失-4,438,941.3--4,050,096-
  财务费用-12,901,290.18-1,253,032.7-
  投资损失593,740.04--5,153,928.52-
  递延所得税7,062,072.76-114,491,878.05-
  其中:递延所得税资产减少12,384,607.7-109,024,753.4-
    递延所得税负债增加-5,322,534.94-5,467,124.65-
  存货的减少-4,523,876.37-18,164,322.57-
  经营性应收项目的减少81,525,773.55-161,222,708.53-
  经营性应付项目的增加-29,294,125.51--113,454,976.5-
  其他-3,852,064.3-11,594,018.73-
  现金的期末余额919,984,783.93-662,115,776.09-
  减:现金的期初余额662,115,776.09-761,367,697.61-
  现金及现金等价物的净增加额257,869,007.84--99,251,921.52-
公告日期2025-08-262025-04-292025-04-292024-10-30
审计意见(境内)标准无保留意见
TOP↑